These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 19742282)

  • 1. Evaluating patients' preferences for multiple myeloma therapy, a Discrete-Choice-Experiment.
    Mühlbacher AC; Lincke HJ; Nübling M
    Psychosoc Med; 2008 Dec; 5():Doc10. PubMed ID: 19742282
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of physicians' perspectives versus patients' preferences: direct assessment and discrete choice experiments in the therapy of multiple myeloma.
    Mühlbacher AC; Nübling M
    Eur J Health Econ; 2011 Jun; 12(3):193-203. PubMed ID: 20107856
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preferences for treatment of Attention-Deficit/Hyperactivity Disorder (ADHD): a discrete choice experiment.
    Mühlbacher AC; Rudolph I; Lincke HJ; Nübling M
    BMC Health Serv Res; 2009 Aug; 9():149. PubMed ID: 19678946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluating the concordance of physician judgments and patient preferences on AIDS/HIV therapy - a Discrete Choice Experiment.
    Mühlbacher AC; Stoll M; Mahlich J; Nübling M
    Health Econ Rev; 2013 Dec; 3(1):30. PubMed ID: 24351422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment preferences of patients with relapsed or refractory multiple myeloma in the United States, United Kingdom, Italy, Germany, France, and Spain: results from a discrete choice experiment.
    Thomas C; Ailawadhi S; Popat R; Kleinman D; Ross MM; Gorsh B; Mulnick S; O'Neill A; Paka P; Hanna M; Krucien N; Molinari A; Gelhorn HL; Perera S
    Front Med (Lausanne); 2023; 10():1271657. PubMed ID: 38076274
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patient preferences for HIV/AIDS therapy - a discrete choice experiment.
    Mühlbacher AC; Stoll M; Mahlich J; Nübling M
    Health Econ Rev; 2013 May; 3(1):14. PubMed ID: 23663390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current Health State Affected Patient Preferences More Than Disease Status: A Discrete Choice Experiment in Multiple Myeloma.
    Tervonen T; Duenas A; Collacott H; Lam A; Gries KS; Carson R; Trevor N; Krucien N; He J
    Value Health; 2023 Jun; 26(6):909-917. PubMed ID: 36738785
    [TBL] [Abstract][Full Text] [Related]  

  • 8. What matters most to patients with multiple myeloma? A Pan-European patient preference study.
    Janssens R; Lang T; Vallejo A; Galinsky J; Morgan K; Plate A; De Ronne C; Verschueren M; Schoefs E; Vanhellemont A; Delforge M; Schjesvold F; Cabezudo E; Vandebroek M; Stevens H; Simoens S; Huys I
    Front Oncol; 2022; 12():1027353. PubMed ID: 36523996
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Real-world treatment preferences among health care providers in the United States in selecting disease modifying therapies for patients with multiple sclerosis: a discrete choice experiment.
    Bandari D; Adamson M; Bowman M; Gutierrez A; Athavale A; Oak B; Hadker N; Branco F; Geremakis C; Lewin JB; Shankar SL
    J Med Econ; 2023; 26(1):1507-1518. PubMed ID: 37934412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myeloma Patient Value Mapping: A Discrete Choice Experiment on Myeloma Treatment Preferences in the UK.
    Fifer S; Galinsky J; Richard S
    Patient Prefer Adherence; 2020; 14():1283-1293. PubMed ID: 32801659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A discrete choice experiment to assess patients' preferences for HIV treatment in the rural population in Colombia.
    Goossens AJM; Cheung KL; Sijstermans E; Conde R; Gonzalez JGR; Hiligsmann M
    J Med Econ; 2020 Aug; 23(8):803-811. PubMed ID: 32098539
    [No Abstract]   [Full Text] [Related]  

  • 12. Alignment of preferences in the treatment of multiple myeloma - a discrete choice experiment of patient, carer, physician, and nurse preferences.
    Fifer SJ; Ho KA; Lybrand S; Axford LJ; Roach S
    BMC Cancer; 2020 Jun; 20(1):546. PubMed ID: 32527324
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relative importance of clinical outcomes and safety risks of antiseizure medication monotherapy for patients and physicians: Discrete choice experiment eliciting preferences in real-world study "VOTE".
    Rosenow F; Winter Y; Leunikava I; Brunnert M; Joeres L; Sutphin J; Boeri M; Smith J; Villani F; Brandt C
    Epilepsia; 2022 Feb; 63(2):451-462. PubMed ID: 34921391
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patient Preferences for Lung Cancer Treatments: A Study Protocol for a Preference Survey Using Discrete Choice Experiment and Swing Weighting.
    Monzani D; Petrocchi S; Oliveri S; Veldwijk J; Janssens R; Bailo L; Smith MY; Smith I; Schoefs E; Nackaerts K; Vandevelde M; Louis E; Decaluwé H; De Leyn P; Declerck H; Katz EG; Petrella F; Casiraghi M; Durosini I; Galli G; Garassino MC; de Wit GA; Pravettoni G; Huys I
    Front Med (Lausanne); 2021; 8():689114. PubMed ID: 34409049
    [No Abstract]   [Full Text] [Related]  

  • 15. Patient preferences and shared decision making for the traditional Chinese medicine treatment of lung cancer: A discrete choice experiment study.
    Teng Y; Wei Y; Chen Y; Yan J; Liu S; Li F; Bao S; Ren Y; Liu L; Yang Y
    Integr Med Res; 2023 Sep; 12(3):100969. PubMed ID: 37546234
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparing the Self-Reported Acceptability of Discrete Choice Experiment and Best-Worst Scaling: An Empirical Study in Patients with Type 2 Diabetes Mellitus.
    Li F; Liu S; Gu Y; Li S; Tao Y; Wei Y; Chen Y
    Patient Prefer Adherence; 2024; 18():1803-1813. PubMed ID: 39229369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Study of Patient Preferences for the Treatment of Non-small Cell Lung Cancer in Western China: A Discrete-Choice Experiment.
    Liu F; Hu H; Wang J; Chen Y; Hui S; Hu M
    Front Public Health; 2021; 9():653450. PubMed ID: 33842426
    [No Abstract]   [Full Text] [Related]  

  • 18. A discrete choice experiment to assess patients' preferences for HIV treatment in the urban population in Colombia.
    Sijstermans E; Cheung KL; Goossens AJM; Conde R; Gonzalez JGR; Hiligsmann M
    J Med Econ; 2020 Aug; 23(8):812-818. PubMed ID: 32098614
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparing Analytic Hierarchy Process and Discrete-Choice Experiment to Elicit Patient Preferences for Treatment Characteristics in Age-Related Macular Degeneration.
    Danner M; Vennedey V; Hiligsmann M; Fauser S; Gross C; Stock S
    Value Health; 2017 Sep; 20(8):1166-1173. PubMed ID: 28964450
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hematologists' Preferences for First-line Therapy Characteristics for Multiple Myeloma in Japan: Attribute Rating and Discrete Choice Experiment.
    Bolt T; Mahlich J; Nakamura Y; Nakayama M
    Clin Ther; 2018 Feb; 40(2):296-308.e2. PubMed ID: 29358004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.